Drug Prices
The Centers for Medicare & Medicaid Services announced in a memo April 21that it is delaying implementation of the Medicare Part D portion of the Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth Model, or BALANCE, for 2027 pending further evaluation and data collection.
The U.S. Court of Appeals for the 5th Circuit today affirmed rulings by a Mississippi district court that rejected requests by Novartis and PhRMA to enjoin enforcement of the state’s law protecting 340B pricing for contract pharmacy arrangements.
The AHA released the 2026 edition of its annual Costs of Caring report. It shows hospitals and health systems continue to face increases in the costs of people, supplies, medicines and infrastructure needed to provide care and services to their communities.
This Costs of Caring report provides a data-driven assessment of the financial realities faced by hospitals and health systems, and underscores why sustainable affordability solutions must address the structural drivers of cost growth rather than focusing narrowly on hospital prices alone.
This report outlines the key trends impacting hospital financial stability in 2025.
The Trump administration has announced a number of agreements with drug companies to lower U.S. drug prices to levels similar to other countries’, and has proposed several new drug payment models through the Center for Medicare & Medicaid Innovation (CMMI).
The AHA commented today on the Centers for Medicare & Medicaid Services’ proposed rule on the Global Benchmark for Efficient Drug Pricing Model, or GLOBE, a new mandatory Medicare payment model issued in December. The model seeks to make most-favored-nation prices available…
The issue of affordability, including health care affordability, is front and center this year and will be part of this year's congressional and administration discussions, as well as the mid-term elections.
AHA Statement before the House Committee on Energy and Commerce
Health Subcommittee on “Lowering Health Care Costs for All Americans: An Examination of the Prescription Drug Supply Chain”
The White House yesterday launched TrumpRx, the direct-to-consumer platform that will serve as a hub to direct cash-paying consumers to drug manufacturers and pharmacies to purchase discounted prescription drugs. The website offers coupons to consumers to purchase drugs at most-…